Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0104 | 0.1487 | 0.1905 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0062 | 0.0413 | 0.037 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0305 | 0.6516 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0144 | 0.2487 | 0.3399 |
Onchocerca volvulus | 0.02 | 0.388 | 0.5244 | |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.016 | 0.2896 | 1 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0104 | 0.1487 | 0.3832 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0104 | 0.1487 | 0.1905 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.02 | 0.388 | 0.615 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0305 | 0.6516 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.02 | 0.388 | 0.615 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.02 | 0.388 | 0.615 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0144 | 0.2487 | 0.3399 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.02 | 0.388 | 0.615 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.02 | 0.388 | 1 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0138 | 0.2335 | 0.8062 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.605 | 1 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.02 | 0.388 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0049 | 0.0101 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0305 | 0.6516 | 1 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.02 | 0.388 | 0.3414 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0062 | 0.0413 | 0.037 |
Schistosoma mansoni | glycogen phosphorylase | 0.0104 | 0.1487 | 0.1487 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.02 | 0.388 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0135 | 0.2251 | 0.3012 |
Mycobacterium ulcerans | hypothetical protein | 0.016 | 0.2896 | 0.7465 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0104 | 0.1487 | 0.3832 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.02 | 0.388 | 0.3414 |
Schistosoma mansoni | hypothetical protein | 0.0135 | 0.2251 | 0.2251 |
Schistosoma mansoni | protein tyrosine phosphatase non-receptor type nt1 | 0.0383 | 0.8497 | 0.8497 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.02 | 0.388 | 0.615 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.5179 | 0.5266 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0104 | 0.1487 | 0.5 |
Onchocerca volvulus | 0.0286 | 0.605 | 1 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.5179 | 0.5266 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0144 | 0.2487 | 0.3643 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0383 | 0.8497 | 1 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0383 | 0.8497 | 1 |
Schistosoma mansoni | glycogen phosphorylase | 0.0104 | 0.1487 | 0.1487 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.02 | 0.388 | 0.615 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0383 | 0.8497 | 1 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0383 | 0.8497 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0305 | 0.6516 | 1 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.02 | 0.388 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.